(Q44973745)

7 December 2017

title

Advantages of cyclosporin A using 2-h levels in pediatric kidney transplantation (English)

1 reference

7 December 2017

1 reference

Lars Pape

1

1 reference

7 December 2017

Jochen H H Ehrich

series ordinal

2

1 reference

7 December 2017

Gisela Offner

series ordinal

3

1 reference

7 December 2017

publication date

10 July 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

19

1 reference

7 December 2017

issue

9

1 reference

7 December 2017

page(s)

1035-1038

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-004-1481-5

7 December 2017

exact match

0 references

cites work

Therapeutic drug monitoring of cyclosporin A: should we use the area under the concentration-time curve and forget trough levels?

1 reference

12 December 2020

Cyclosporin A monitoring by 2-h levels: preliminary target levels in stable pediatric kidney transplant recipients

1 reference

12 December 2020

Patient management by Neoral C(2) monitoring: an international consensus statement

1 reference

12 December 2020

Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients

1 reference

12 December 2020

Recommendations for the implementation of Neoral C(2) monitoring in clinical practice

1 reference

12 December 2020

Reduced variability of neoral pharmacokinetic studies in pediatric renal transplantation

1 reference

12 December 2020

Refining immunosuppressive protocols in pediatric renal transplant recipients

1 reference

12 December 2020

Abbreviated cyclosporine AUCs on Neoral--the search continues!

1 reference

12 December 2020

Optimization of cyclosporine exposure utilizing C(2) level monitoring in de novo renal transplant recipients: the Toronto General Hospital experience

1 reference

12 December 2020

Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation

1 reference

12 December 2020

Randomized, international study of cyclosporine microemulsion absorption profiling in renal transplantation with basiliximab immunoprophylaxis

1 reference

12 December 2020

Neoral monitoring 2 hours post-dose and the pediatric transplant patient

1 reference

12 December 2020

Cyclosporine peak concentration in relation to the four-hour absorption phase in pediatric renal graft recipients

1 reference

12 December 2020

Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation

1 reference

12 December 2020

Single-center study utilizing C(2) level as monitoring tool in de novo renal transplant recipients treated with Neoral

1 reference

12 December 2020

Excessive cyclosporine trough level variation with classic cyclosporine can be reduced with the new oral microemulsion formulation of cyclosporine

1 reference

12 December 2020

A limited sampling strategy for the estimation of Neoral AUCs in pediatric patients

1 reference

12 December 2020

Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2).

1 reference

12 December 2020

Sandimmune to Neoral conversion and value of abbreviated AUC monitoring in stable pediatric kidney transplant recipients

1 reference

12 December 2020

Neoral C(2) monitoring in pediatric liver transplant recipients

1 reference

12 December 2020

The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents

1 reference

12 December 2020

Cyclosporine A monitoring in children: abbreviated area under curve formulas and C2 level

1 reference

12 December 2020

Clinical validation studies of Neoral C(2) monitoring: a review

1 reference

12 December 2020

Clinical benefit of neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients

1 reference

12 December 2020

10.1007/S00467-004-1481-5

Identifiers

DOI

1 reference

7 December 2017

1 reference